Haleon: Too Vanilla For My Liking - I See Why GSK & Pfizer Wanted Out
Haleon was spun off from GSK amid investor pressure, showing steady growth but facing debt concerns. See more about HLN stock ...
Morningstar5d
Haleon Backs Guidance Despite Revenue, Profit Miss
Haleon backed its full-year guidance despite ... healthcare business--which was spun out of GSK and is partly owned by Pfizer--said Thursday that revenue for the quarter was 2.78 billion pounds ...
The Motley Fool5d
3 Factors That Make Pfizer's Ultra-High-Yield Dividend Safer Than You Might Think
During the same period, the company received roughly $6.9 billion of net cash proceeds from the sale of its shares of Haleon, a consumer health joint venture with GSK. In Pfizer's Q3 earnings call ...
Pfizer CEO, Under Fire, Will Do ‘Whatever It Takes’ to Grow
Pfizer Inc. Chief Executive Officer Albert Bourla said he’ll do “whatever it takes” to keep profits growing, including ...
Pfizer Reports Strong Third-Quarter 2024 Results And Raises 2024 Guidance
Pfizer Inc. (NYSE: PFE) reported financial results for the third quarter of 2024 and raised its full-year 2024 guidance(1) ...
Business Times7d
Pfizer's Covid-19 drug powers strong quarterly profit as activist hovers
Pfizer, which is under pressure from activist investor Starboard, on Tuesday (Oct 29) topped third-quarter estimates as sales of its Covid-19 treatment Paxlovid blew past Wall Street expectations.
ABC News7d
Pfizer rides Paxlovid sales growth to better-than-expected third quarter
A boost from COVID-19 treatment sales helped bush Pfizer to a better-than-expected third quarter and higher forecast for the year A boost from COVID-19 treatment sales helped bush Pfizer to a ...
3 Factors That Make Pfizer's Ultra-High-Yield Dividend Safer Than You Might Think
Is it true that the higher the dividend yield, the riskier the dividend? Not always. Some companies with exceptionally high ...